Mercer Global Advisors
MDCX

Mercer Global Advisors’s Medicus Pharma MDCX Stock Holding History

Mercer Global Advisors’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223 Buy
+500
New +$177 ﹤0.01% 5913

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.5B AUM 19.97% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mercer Global Advisors's MDCX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Medicus Pharma (MDCX) in Q2 2026: 500 shares worth $223. The stake represents ﹤0.01% of the portfolio and ranks #5913 among its holdings.

15 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Mercer Global Advisors held 500 shares of Medicus Pharma worth $223 as of Q2 2026.
  • Medicus Pharma was a new Mercer Global Advisors position in Q2 2026.
  • Medicus Pharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5913 holding.
  • 15 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.